COGT logo

Cogent Biosciences (COGT) Company Overview

Profile

Full Name:

Cogent Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 29, 2018

Indexes:

Not included

Description:

Cogent Biosciences focuses on developing innovative therapies for genetic diseases, particularly those caused by mutations in specific genes. The company aims to improve patient outcomes through targeted treatments, using advanced science and technology to address unmet medical needs in rare and serious conditions.

Events Calendar

Earnings

Next earnings date:

Feb 26, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 9, 2020

Analyst ratings

Recent major analysts updates

Jan 14, 25 HC Wainwright & Co.
Buy
Dec 11, 24 Needham
Hold
Dec 11, 24 HC Wainwright & Co.
Buy
Dec 10, 24 Needham
Buy
Dec 9, 24 Needham
Buy
Nov 14, 24 JP Morgan
Overweight
Nov 13, 24 Needham
Buy
Nov 4, 24 HC Wainwright & Co.
Buy
Oct 24, 24 Needham
Buy
Sep 24, 24 Citigroup
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cogent Biosciences?
  • Does Cogent Biosciences pay dividends?
  • What sector is Cogent Biosciences in?
  • What industry is Cogent Biosciences in?
  • What country is Cogent Biosciences based in?
  • When did Cogent Biosciences go public?
  • Is Cogent Biosciences in the S&P 500?
  • Is Cogent Biosciences in the NASDAQ 100?
  • Is Cogent Biosciences in the Dow Jones?
  • When was Cogent Biosciences's last earnings report?
  • When does Cogent Biosciences report earnings?
  • Should I buy Cogent Biosciences stock now?

What is the ticker symbol for Cogent Biosciences?

The ticker symbol for Cogent Biosciences is NASDAQ:COGT

Does Cogent Biosciences pay dividends?

No, Cogent Biosciences does not pay dividends

What sector is Cogent Biosciences in?

Cogent Biosciences is in the Healthcare sector

What industry is Cogent Biosciences in?

Cogent Biosciences is in the Biotechnology industry

What country is Cogent Biosciences based in?

Cogent Biosciences is headquartered in United States

When did Cogent Biosciences go public?

Cogent Biosciences's initial public offering (IPO) was on March 29, 2018

Is Cogent Biosciences in the S&P 500?

No, Cogent Biosciences is not included in the S&P 500 index

Is Cogent Biosciences in the NASDAQ 100?

No, Cogent Biosciences is not included in the NASDAQ 100 index

Is Cogent Biosciences in the Dow Jones?

No, Cogent Biosciences is not included in the Dow Jones index

When was Cogent Biosciences's last earnings report?

Cogent Biosciences's most recent earnings report was on Nov 12, 2024

When does Cogent Biosciences report earnings?

The next expected earnings date for Cogent Biosciences is Feb 26, 2025

Should I buy Cogent Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions